Summit Global Investments’s iRadimed IRMD Stock Holding History
Bought
Maintained
Sold
Other funds holding IRMD
CCM
VCM
NTCM
Summit Global Investments's IRMD Position: Q1 2026 in Review
Summit Global Investments increased its iRadimed (IRMD) stake by 8.2% in Q1 2026, buying an estimated $57.9K and bringing the position to 7,661 shares worth $737K. The position accounts for 0.04% of the portfolio, ranked #261.
Summit Global Investments first reported a position in IRMD in Q1 2020 and has held it in 17 quarters since. 228 funds tracked by Wall St. Rank hold IRMD as of Q1 2026.
- Summit Global Investments held 7,661 shares of iRadimed worth $737K as of Q1 2026.
- Summit Global Investments bought 579 iRadimed shares in Q1 2026, an estimated $57.9K.
- iRadimed made up 0.04% of Summit Global Investments's portfolio in Q1 2026, its #261 holding.
- Summit Global Investments first reported a position in iRadimed in Q1 2020 and has held it in 17 quarters since.
- 228 funds tracked by Wall St. Rank held iRadimed as of Q1 2026.
Based on Summit Global Investments's 13F filing for Q1 2026, filed 7 May 2026.